Bhardwaj Anish
Department of Neurology, Oregon Health & Science University, Portland, OR 97239-3098, USA.
Curr Neurol Neurosci Rep. 2007 Nov;7(6):513-21. doi: 10.1007/s11910-007-0079-2.
Osmotherapy is the mainstay in the medical management of cerebral edema with or without elevations in intracranial pressure. Several osmotic agents have been utilized in clinical practice over the past five decades in a variety of brain injury paradigms. The over-riding premise for their beneficial effects has been via egress of water from the brain into the vascular compartment. In addition, many of these agents have beneficial extraosmotic properties that portend their use in cerebral resuscitation and treatment of cerebral edema. Although there is a paucity of large, randomized clinical trials that compare various osmotic agents, data are emerging from prospective clinical case series. This article provides a historical perspective of osmotherapy, examines characteristics of osmotic agents, and discusses caveats in their use in the clinical setting. Furthermore, this review highlights the utility of osmotic agents as tools to understand emerging mechanistic concepts in the evolution of brain edema, which are yielding important data of translational significance from laboratory-based research.
渗透疗法是治疗伴有或不伴有颅内压升高的脑水肿的主要医学手段。在过去的五十年里,几种渗透剂已被应用于各种脑损伤模型的临床实践中。它们产生有益作用的首要前提是通过水从脑内进入血管腔。此外,其中许多药物具有有益的非渗透特性,这预示着它们可用于脑复苏和脑水肿的治疗。尽管比较各种渗透剂的大型随机临床试验较少,但前瞻性临床病例系列的数据正在不断涌现。本文提供了渗透疗法的历史视角,研究了渗透剂的特性,并讨论了其在临床应用中的注意事项。此外,本综述强调了渗透剂作为工具在理解脑水肿演变中新兴机制概念方面的效用,这些机制概念正从基于实验室的研究中产生具有转化意义的重要数据。